Clinical Trial Update: Antineoplaston Therapy in Treating Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of antineoplaston therapy for women with advanced breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Stage IV Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: WITHDRAWN